Medical Device

Found 13,814 articles

• Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024

  3/15/2024

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient, announced that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024.

• QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units

  3/15/2024

  QT Imaging Holdings, Inc., a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter market, effective as of March 11, 2024.

• ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

  3/15/2024

  ResMed, the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, COPD, and other chronic diseases, announced the results of its 2024 Global Sleep Survey in conjunction with World Sleep Day, shedding light on the critical sleep challenges faced by people around the world.

• BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024

  3/14/2024

  BIOLASE, Inc. announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

• Sensus Healthcare to Participate in the 36th Annual Roth Conference

  3/14/2024

  Sensus Healthcare, Inc. announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.

• New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities

  3/13/2024

  BD, a leading global medical technology company, announced new data from a research study evaluating the impact of deploying automated dispensing cabinets in long-term care facilities and an off-site, long-term care pharmacy.

• Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

  3/13/2024

  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the successful launch of its new “Fair Deal Agreement” for the SRT-100 Vision™ (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego.

• SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

  3/12/2024

  SeaStar Medical Holding Corporation provides updates on the acute kidney injury (AKI) programs it is developing with its patented, first-to-market, cell-directed Selective Cytopheretic Device (SCD) extracorporeal therapy in critically ill patients with AKI.

• Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

  3/12/2024

  Inari Medical, Inc. a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive two-year interim results from the CLOUT registry.

• Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealand

  3/12/2024

  Casio Computer Co., Ltd. announced that the DZ-C100 COLPOCAMERA, which is designed for uterocervical observation and photography in gynecological settings, and the CST-100M camera stand are released in the US, Australia and New Zealand.

• Mainstay Medical Announces Publication of Clinical Results Comparing Older Patients and Younger Patients

  3/12/2024

  Mainstay Medical Holdings plc announced the publication of a pooled analysis of three different clinical studies that evaluated the safety and efficacy of ReActiv8 therapy after two years in patients of various ages.

• Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR

  3/11/2024

  Edwards Lifesciences announced at Cardiovascular Research Technologies 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform.

• ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System

  3/11/2024

  ONWARD Medical N.V. announces that it has been accepted into the US FDA’s new Total Product Lifecycle Advisory Program for its brain-computer interface technology.

• INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

  3/11/2024

  MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced initial meal challenge data from INHALE-3 that was presented by Dr. Irl B. Hirsch at the 17th International Conference on Advanced Technologies and Treatments for Diabetes in Florence on March 8th.

• Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

  3/8/2024

  Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, presented positive results from its first randomized controlled trial showing improved glycemic and patient-reported outcomes in type 1 diabetes with the Omnipod 5 Automated Insulin Delivery System.

• Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

  3/8/2024

  Silk Road Medical, a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® Transcarotid Stent System, in China.

• Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems

  3/7/2024

  Sharps Technology, Inc. and Roncadelle Operations have signed a sales and distribution agreement to cooperatively sell and distribute each other’s products to their respective areas of influence.

• Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

  3/7/2024

  Helius Medical Technologies, Inc. announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the 36th Annual ROTH Conference, March 17-19, 2024, Laguna Nigel, CA, as follows.

• Hope for Women: Womed Unveils First Fertility Restoration Device Proven Effective in Randomized Clinical Trial

  3/7/2024

  Womed, the women's health company pioneering innovative, safe and effective treatments to free women from uterine pathologies, announced that the results of the PREG2 clinical trial demonstrated Womed Leaf® is effective in the management of severe and moderate intrauterine adhesions, the primary mechanical cause for female infertility.

• Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

  3/7/2024

  Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders held March 6, 2024.